Agenus
AGEN
#8939
Rank
A$0.20 B
Marketcap
A$6.14
Share price
-2.64%
Change (1 day)
15.09%
Change (1 year)

Agenus (AGEN) - Cash on Hand

Cash on Hand as of September 2025 : A$5.22 Million

According to Agenus 's latest financial reports the company has A$5.22 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Agenus - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$65.01 M-41.81%
2023-12-31A$0.11 B-60.68%
2022-12-31A$0.28 B-32.88%
2021-12-31A$0.42 B225.95%
2020-12-31A$0.12 B47.13%
2019-12-31A$88.27 M17.22%
2018-12-31A$75.31 M-2.31%
2017-12-31A$77.09 M-27.3%
2016-12-31A$0.10 B-55%
2015-12-31A$0.23 B379.45%
2014-12-31A$49.14 M60.28%
2013-12-31A$30.66 M48.43%
2012-12-31A$20.65 M97.08%
2011-12-31A$10.48 M-46.18%
2010-12-31A$19.47 M-41.81%
2009-12-31A$33.46 M-31.48%
2008-12-31A$48.84 M128.63%
2007-12-31A$21.36 M-57.99%
2006-12-31A$50.86 M-39.73%
2005-12-31A$84.38 M-24.87%
2004-12-31A$0.11 B-6.69%
2003-12-31A$0.12 B15.49%
2002-12-31A$0.10 B-12.6%
2001-12-31A$0.11 B-32.74%
2000-12-31A$0.17 B151.12%
1999-12-31A$70.61 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Merck
MRK
A$27.52 B 526,620.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$6.71 B 128,424.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$28.05 B 536,684.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.88 B 16,765.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$24.94 B 477,112.26%๐Ÿ‡บ๐Ÿ‡ธ USA